基本數據
| CIK | 1829247 |
SEC Filings
All companies that sell securities in the United States must register with the Securities and Exchange Commission (SEC) and file reports on a regular basis.
These reports include company annual reports (10K, 10Q), news updates (8K), investor presentations (found in 8Ks), insider trades (form 4), ownership reports (13D, and 13G), and reports related to the specific securities sold, such as registration statements and prospectus. This page shows recent SEC filings related to Bullfrog AI Holdings, Inc.
SEC Filings (Chronological Order)
本頁面提供了一個完整的、按時間順序排列的美國證券交易委員會（SEC）申報文件列表，不包括我們在其他地方提供的所有權申報。
| May 29, 2026 |
As filed with the Securities and Exchange Commission on May 29, 2026. As filed with the Securities and Exchange Commission on May 29, 2026. Registration Statement No. 333- UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 BULLFROG AI HOLDINGS, INC. (Exact name of Registrant as specified in its charter) Nevada 001-41600 84-4786155 (State or other jurisdiction of incorporation) (Com |
|
| May 29, 2026 |
Calculation of Filing Fee Tables S-1 BullFrog AI Holdings, Inc. Table 1: Newly Registered and Carry Forward Securities ☐Not Applicable Security Type Security Class Title Fee Calculation or Carry Forward Rule Amount Registered Proposed Maximum Offering Price Per Unit Maximum Aggregate Offering Price Fee Rate Amount of Registration Fee Carry Forward Form Type Carry Forward File Number Carry Forward |
|
| May 14, 2026 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2026 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 001-41600 BULLFROG AI HOLDINGS, |
|
| May 1, 2026 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a–6(e)(2)) ☐ Defin |
|
| April 30, 2026 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☒ Definitive |
|
| April 22, 2026 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 22, 2026 BULLFROG AI HOLDINGS, INC. |
|
| April 22, 2026 |
Exhibit 99.1 BullFrog AI Regains Compliance with Nasdaq Shareholders’ Equity Requirement Strengthened balance sheet provides capital runway into late 2027 GAITHERSBURG, Md., April 22, 2026 — BullFrog AI Holdings, Inc. (NASDAQ: BFRG; BFRGW) (“BullFrog AI” or the “Company”), a technology company using artificial intelligence (“AI”) and machine learning to turn complex biomedical data into actionable |
|
| April 21, 2026 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 15, 2026 BULLFROG AI HOLDINGS, INC. |
|
| April 13, 2026 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 13, 2026 BULLFROG AI HOLDINGS, INC. |
|
| April 13, 2026 |
Exhibit 99.1 BullFrog AI Provides Business Update: Strengthened Balance Sheet Supports Continued Execution as Company Aims to Ramp Commercial Activity with Global Pharmaceutical and Biotechnology Partners First commercial agreement with a top 5 global pharmaceutical company anchors a growing pipeline of enterprise discussions; runway secured into late 2027 GAITHERSBURG, Md., April 13, 2026 (GLOBE |
|
| April 1, 2026 |
BullFrog AI Holdings, Inc. Up to $4.3 million Of Shares of Common Stock Filed pursuant to Rule 424(b)(5) Registration No. 333-281341 PROSPECTUS SUPPLEMENT (To the Prospectus dated August 21, 2024, the Prospectus Supplement dated April 25, 2025, and the Prospectus Supplement dated November 7, 2025) BullFrog AI Holdings, Inc. Up to $4.3 million Of Shares of Common Stock This prospectus supplement (this “Prospectus Supplement No. 3”) amends and supplements certain inform |
|
| April 1, 2026 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 31, 2026 BULLFROG AI HOLDINGS, INC. |
|
| March 30, 2026 |
Exhibit 10.1 CERTAIN INFORMATION HAS BEEN EXCLUDED FROM THIS EXHIBIT BECAUSE IT IS NOT MATERIAL AND IS THE TYPE THAT THE REGISTRANT TREATS AS PRIVATE OR CONFIDENTIAL. THE OMITTED PORTIONS OF THIS DOCUMENT ARE INDICATED BY [***]. FEASIBILITY AGREEMENT [***] and its affiliates (“[***]”) desire to retain BullFrog AI Holdings, Inc. (“Company”), with an address of 325 Ellington Blvd. #317 Gaithersburg, |
|
| March 30, 2026 |
Exhibit 99.1 BullFrog AI Announces Commercial Agreement with Top 5 Global Pharmaceutical Company to Identify and Prioritize Therapeutic Target in Major Depressive Disorder Commercial agreement serves as high-profile third party validation of BullFrog AI’s proprietary capabilities Agreement utilizes BullFrog AI’s end-to-end analytical AI platform to accelerate drug discovery and development program |
|
| March 30, 2026 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 27, 2026 BULLFROG AI HOLDINGS, INC. |
|
| March 19, 2026 |
Bullfrog AI Holdings, Inc. Stock Grant Notice (2022 Equity Compensation Plan) Exhibit 10.22 Bullfrog AI Holdings, Inc. Stock Grant Notice (2022 Equity Compensation Plan) Bullfrog AI Holdings, Inc. (the “Company”), pursuant to Section 10 of the Company’s 2022 Equity Compensation Plan, as amended from time-to-time (the “Plan”), hereby awards to Participant that number of shares of the Company’s Common Stock (“Common Stock”) set forth below (the “Award”). The Award is evidence |
|
| March 19, 2026 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended: December 31, 2025 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from [ ] to [ ] Commission file number 001-41600 BULLFROG |
|
| March 19, 2026 |
BULLFROG AI HOLDINGS, INC. 2025 REFRESH RESTRICTED STOCK UNIT AWARD AGREEMENT Exhibit 10.23 BULLFROG AI HOLDINGS, INC. 2025 REFRESH RESTRICTED STOCK UNIT AWARD AGREEMENT [] This 2025 REFRESH RESTRICTED STOCK UNIT AWARD AGREEMENT (this “Agreement”) dated as of [] (the “Date of Grant”), is made by Bullfrog AI Holdings, Inc., a Nevada corporation (the “Company”), to [] (the “Participant”). RECITALS The 2022 Equity Compensation Plan of the Company (the “Plan”) provides for the |
|
| March 19, 2026 |
List of Subsidiaries of BullFrog AI Holdings, Inc. Exhibit 21.1 List of Subsidiaries of BullFrog AI Holdings, Inc. Name of Subsidiary Jurisdiction of Incorporation or Organization BullFrog AI, Inc Delaware BullFrog Management, LLC Maryland |
|
| February 23, 2026 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 19, 2026 BULLFROG AI HOLDINGS, INC. |
|
| February 17, 2026 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 10, 2026 BULLFROG AI HOLDINGS, INC. |
|
| December 30, 2025 |
Exhibit 99.1 BullFrog AI Publishes Annual Letter to Shareholders Highlights significant progress in 2025 and outlines commercial priorities and potential catalysts entering 2026 GAITHERSBURG, Md., December 30, 2025 (GLOBE NEWSWIRE) — BullFrog AI Holdings, Inc. (NASDAQ: BFRG; BFRGW) (“BullFrog AI” or the “Company”), a technology-enabled drug development company using artificial intelligence (“AI”) |
|
| December 30, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 30, 2025 BULLFROG AI HOLDINGS, INC. |
|
| December 1, 2025 |
BULLFROG AI HOLDINGS, INC. Up to 5,000,000 Shares of Common Stock Filed pursuant to Rule 424(b)(3) Registration Statement No. 333-290840 Prospectus BULLFROG AI HOLDINGS, INC. Up to 5,000,000 Shares of Common Stock This prospectus relates to the resale, from time to time, of up to 5,000,000 shares of our common stock, par value $0.00001 per share, by Lincoln Park Capital Fund, LLC, which we refer to in this prospectus as “Lincoln Park” or the “selling stockholder |
|
| November 24, 2025 |
BullFrog AI Holdings, Inc. 325 Ellington Blvd, Unit 317 Gaithersburg, MD 20878 November 24, 2025 BullFrog AI Holdings, Inc. 325 Ellington Blvd, Unit 317 Gaithersburg, MD 20878 November 24, 2025 VIA EDGAR United States Securities and Exchange Commission Division of Corporation Finance, Office of Life Science 100 F Street, NE Washington, D.C. 20549 Re: BullFrog AI Holdings, Inc. Registration Statement on Form S-1 (File No. 333-290840) Ladies and Gentlemen: Pursuant to Rule 461 under the Securit |
|
| November 14, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2025 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 001-41600 BULLFROG AI HOLDI |
|
| November 7, 2025 |
BullFrog AI Holdings, Inc. Up to $2.0 million Of Shares of Common Stock Filed pursuant to Rule 424(b)(5) Registration No. 333-281341 PROSPECTUS SUPPLEMENT (To the Prospectus dated August 21, 2024 and Prospectus Supplement dated April 25, 2025) BullFrog AI Holdings, Inc. Up to $2.0 million Of Shares of Common Stock This prospectus supplement (this “Prospectus Supplement No. 2”) amends and supplements certain information in our prospectus, dated August 21, 2024 (the “Ba |
|
| October 24, 2025 |
BULLFROG AI HOLDINGS, INC. AMENDMENT NO. 1 TO 2022 EQUITY INCENTIVE PLAN EFFECTIVE DATE: Exhibit 10.1 BULLFROG AI HOLDINGS, INC. AMENDMENT NO. 1 TO 2022 EQUITY INCENTIVE PLAN EFFECTIVE DATE: This Amendment No. 1, dated and effective October 22, 2025 (the “Amendment”), is an amendment to the 2022 Equity Incentive Plan (the “Plan”), of Bullfrog AI Holdings, Inc., a Nevada corporation (the “Company”). All capitalized terms used in this Amendment without definition have the meanings set f |
|
| October 24, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 22, 2025 BULLFROG AI HOLDINGS, INC. |
|
| October 10, 2025 |
As filed with the Securities and Exchange Commission on October 10, 2025. As filed with the Securities and Exchange Commission on October 10, 2025. Registration Statement No. 333- UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 BULLFROG AI HOLDINGS, INC. (Exact name of Registrant as specified in its charter) Nevada 001-41600 84-4786155 (State or other jurisdiction of incorporation) |
|
| October 10, 2025 |
Exhibit 107 Calculation of Filing Fee Tables Form S-1 (Form Type) BullFrog AI Holdings, Inc. |
|
| October 10, 2025 |
BYLAWS OF BULLFROG Al HOLDINGS, INC. ARTICLE I Name and Principal Office Exhibit 3.2 BYLAWS OF BULLFROG Al HOLDINGS, INC. ARTICLE I Name and Principal Office Section 1. The name of this corporation is: BULLFROG Al HOLDINGS, INC. Section 2. The principal office of the corporation shall be located at such place as shall be designated by the Board of Directors, and it may maintain branch offices or agents elsewhere, within or without the State of Nevada, as the Board of D |
|
| October 9, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 7, 2025 BULLFROG AI HOLDINGS, INC. |
|
| September 26, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary proxy statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☒ Definitive |
|
| September 24, 2025 |
September 24, 2025 Josh Blacher Chief Financial Officer BullFrog AI Holdings, Inc. |
|
| September 23, 2025 |
Certificate of Amendment of the Bylaws of Bullfrog AI Holdings, Inc. Exhibit 3.1 Certificate of Amendment of the Bylaws of Bullfrog AI Holdings, Inc. I, Josh Blacher, in my capacity as Secretary of Bullfrog AI Holdings, Inc., a Nevada corporation (the “Company”), certify that on September 18, 2025, the Board of Directors of the Company adopted a resolution approving an amendment to the Bylaws of the Company (the “Bylaws”) as provided below, pursuant to Article XII |
|
| September 23, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 18, 2025 BULLFROG AI HOLDINGS, INC. |
|
| September 17, 2025 |
Peter Jaslow Tel: 856.761.3447 Fax: 215.864.8999 [email protected] September 17, 2025 By EDGAR Division of Corporation Finance Office of Life Sciences United States Securities and Exchange Commission Washington, D.C. 20549 Attn: Tracie Mariner Jenn Do Re: BullFrog AI Holdings, Inc. Form 10-K for Fiscal Year Ended December 31, 2024 File No. 001-41600 Ladies and Gentlemen: This letter respond |
|
| September 16, 2025 |
Exhibit 10.1 PURCHASE AGREEMENT PURCHASE AGREEMENT (the “Agreement”), dated as of September 15, 2025, by and between BULLFROG AI HOLDINGS, INC., a Nevada corporation (the “Company”), and LINCOLN PARK CAPITAL FUND, LLC, an Illinois limited liability company (the “Investor”). WHEREAS: Subject to the terms and conditions set forth in this Agreement, the Company wishes to sell to the Investor, and the |
|
| September 16, 2025 |
Exhibit 10.2 REGISTRATION RIGHTS AGREEMENT REGISTRATION RIGHTS AGREEMENT (this “Agreement”), dated as of September 15, 2025, by and between BULLFROG AI HOLDINGS, INC., a Nevada corporation (the “Company”), and LINCOLN PARK CAPITAL FUND, LLC, an Illinois limited liability company (together with its permitted assigns, the “Buyer”). Capitalized terms used herein and not otherwise defined herein shall |
|
| September 16, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 15, 2025 BULLFROG AI HOLDINGS, INC. |
|
| September 16, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☒ Preliminary proxy statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☐ Definitive |
|
| September 10, 2025 |
September 10, 2025 Josh Blacher Chief Financial Officer BullFrog AI Holdings, Inc. |
|
| August 27, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 21, 2025 BULLFROG AI HOLDINGS, INC. |
|
| August 13, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2025 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 001-41600 BULLFROG AI HOLDINGS, |
|
| August 8, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☒ Definitive |
|
| June 12, 2025 |
Exhibit 99.1 BullFrog AI Announces Strategic Collaboration with Sygnature Discovery to Introduce BullFrog Data Networks™ to Global Biopharma Clients GAITHERSBURG, Md., June 12, 2025 (GLOBE NEWSWIRE) — BullFrog AI Holdings, Inc. (NASDAQ: BFRG; BFRGW) (“BullFrog AI” or the “Company”), a technology-enabled drug development company using artificial intelligence (AI) and machine learning to enable the |
|
| June 12, 2025 |
Other Events, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 12, 2025 BULLFROG AI HOLDINGS, INC. |
|
| May 13, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2025 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 001-41600 BULLFROG AI HOLDINGS, |
|
| April 28, 2025 |
Entry into a Material Definitive Agreement, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 25, 2025 BULLFROG AI HOLDINGS, INC. (Exact name of Registrant as Specified in Its Charter) Nevada 001-41600 84-4786155 (State or Other Jurisdiction of Incorporation) (Commission |
|
| April 28, 2025 |
Exhibit 1.1 BULLFROG AI Holdings, INC. UP TO $20,000,000 OF COMMON STOCK (par value $0.00001 per share) At-the-market SALES AGREEMENT April 25, 2025 BTIG, LLC 65 East 55th Street New York, New York 10022 Ladies and Gentlemen: Bullfrog AI Holdings, Inc., a Nevada corporation (the “Company”), confirms its agreement (this “Agreement”) with BTIG, LLC (“BTIG” and, together with the Company, the “Partie |
|
| April 25, 2025 |
Bullfrog AI Holdings, Inc. Up to $3.1 million Of Shares of Common Stock Filed pursuant to Rule 424(b)(5) Registration No. 333-281341 PROSPECTUS SUPPLEMENT (To the Prospectus dated August 21, 2024) Bullfrog AI Holdings, Inc. Up to $3.1 million Of Shares of Common Stock We have entered into an At-the-Market Sales Agreement, or the Sales Agreement, with BTIG, LLC, or the sales agent, relating to shares of our common stock offered by this prospectus supplement. In accorda |
|
| March 14, 2025 |
Exhibit 14.1 Bullfrog AI Holdings, Inc. Code of Business Conduct and Ethics I. Introduction A. Purpose This Code of Business Conduct and Ethics (the “Code”) contains general guidelines for conducting the business of Bullfrog AI Holdings, Inc. (the “Company” or “we”) consistent with the highest standards of business ethics. To the extent this Code requires a higher standard than required by commerc |
|
| March 14, 2025 |
Exhibit 97.1 bullfrog ai holdings, Inc. Compensation Recoupment Policy 1. Restatement. In the event of any required accounting restatement of the financial statements of Bullfrog AI Holdings, Inc. (the “Company”) due to the material noncompliance of the Company with any financial reporting requirement under the applicable U.S. federal securities laws, including any required accounting restatement |
|
| March 14, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended: December 31, 2024 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from [ ] to [ ] Commission file number 001-41600 BULLFROG |
|
| March 14, 2025 |
Form of Stock Option Grant Agreement Exhibit 10.15 BULLFROG AI HOLDINGS, INC. 2022 EQUITY INCENTIVE PLAN Stock Option Agreement This STOCK OPTION AGREEMENT (this “Agreement”), made and entered into on the th day of January 2025 (the “Grant Date”), by and between (the “Participant”) and Bullfrog AI Holdings, Inc., a Nevada corporation (the “Company”), sets forth the terms and conditions of stock options issued to the Participant pursu |
|
| March 14, 2025 |
Exhibit 4.13 BULLFROG AI HOLDINGS, INC DESCRIPTION OF SECURITIES REGISTERED PURSUANT TO SECTION 12 OF THE SECURITIES EXCHANGE ACT OF 1934 The Common Stock, with par value of $0.00001 per share (“Common Stock”), and the warrants for shares of the Common Stock (the “Tradeable Warrants”) of Bullfrog AI Holdings, Inc. (the “Company”) are the only classes of our securities registered under Section 12 o |
|
| March 14, 2025 |
Exhibit 10.14 INDEMNIFICATION AGREEMENT This Indemnification Agreement (“Agreement”), dated as of , is by and between Bullfrog AI Holdings, Inc., a Nevada corporation (the “Company”) and (the “Indemnitee”). Whereas, Indemnitee is a director of the Company; Whereas, both the Company and Indemnitee recognize the increased risk of litigation and other claims being asserted against directors and offic |
|
| March 14, 2025 |
Exhibit 19.1 Bullfrog AI Holdings, Inc. Insider Trading Compliance Policy This Insider Trading Compliance Policy (this “Policy”) consists of seven sections: ● Section I provides an overview; ● Section II sets forth the policies of the Company prohibiting insider trading; ● Section III explains insider trading; ● Section IV consists of procedures that have been put in place by the Company to preven |
|
| February 27, 2025 |
Exhibit 99.1 BullFrog AI and Eleison Pharmaceuticals Enter Agreement to Collaborate to Optimize Pivotal Phase 3 Trial Eleison to leverage BullFrog Data NetworksTM to enhance patient clustering and safety analysis in glufosfamide clinical trials GAITHERSBURG, Md., Feb. 27, 2025 (GLOBE NEWSWIRE) — BullFrog AI Holdings, Inc. (NASDAQ: BFRG; BFRGW) (“BullFrog AI” or the “Company”), a technology-enabled |
|
| February 27, 2025 |
Other Events, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 27, 2025 BULLFROG AI HOLDINGS, INC. |
|
| January 14, 2025 |
JOINT ACQUISITION STATEMENT PURSUANT TO RULE 13d-1(k) EXHIBIT 99.1 JOINT ACQUISITION STATEMENT PURSUANT TO RULE 13d-1(k) The undersigned acknowledge and agree that the foregoing statement on Schedule 13G is filed on behalf of each of the undersigned and that all subsequent amendments to this statement on Schedule 13G shall be filed on behalf of each of the undersigned without the necessity of filing additional joint acquisition statements. The unders |
|
| December 27, 2024 |
Other Events, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 27, 2024 BULLFROG AI HOLDINGS, INC. |
|
| December 27, 2024 |
BullFrog AI Issues Letter to Stockholders Exhibit 99.1 BullFrog AI Issues Letter to Stockholders GAITHERSBURG, Md., Dec. 27, 2024 (GLOBE NEWSWIRE) — BullFrog AI Holdings, Inc. (NASDAQ: BFRG; BFRGW) (“BullFrog AI” or the “Company”), a technology-enabled drug development company using artificial intelligence (AI) and machine learning to enable the successful development of pharmaceuticals and biologics, issued a letter to stockholders from |
|
| December 17, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 12, 2024 BULLFROG AI HOLDINGS, INC. |
|
| December 17, 2024 |
BullFrog AI Announces Appointment of Chief Financial Officer Exhibit 99.1 BullFrog AI Announces Appointment of Chief Financial Officer GAITHERSBURG, Md., Dec. 17, 2024 (GLOBE NEWSWIRE) — BullFrog AI Holdings, Inc. (NASDAQ: BFRG; BFRGW) (“BullFrog AI” or the “Company”), a technology-enabled drug development company using artificial intelligence (AI) and machine learning to enable the successful development of pharmaceuticals and biologics, today announced th |
|
| December 17, 2024 |
Exhibit 10.1 MASTER SERVICES AGREEMENT This Master Services Agreement (the “Agreement”) is made effective as of December 13, 2024 (the “Effective Date”), by and between Bullfrog AI Holdings, Inc., a Nevada corporation, with its principal place of business being 325 Ellington Blvd., Unit 317, Gaithersburg, MD 20878 (the “Company”), and Danforth Global, Inc., a Delaware corporation, with its princip |
|
| December 12, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 7, 2024 BULLFROG AI HOLDINGS, INC. |
|
| November 26, 2024 |
BullFrog AI Holdings, Inc. 325 Ellington Blvd., Unit 317 Gaithersburg, MD 20878 (240) 658-6710 BullFrog AI Holdings, Inc. 325 Ellington Blvd., Unit 317 Gaithersburg, MD 20878 (240) 658-6710 November 26, 2024 VIA EDGAR Securities and Exchange Commission Division of Corporation Finance 100 F Street N.E. Washington, D.C. 20549 Re: BullFrog AI Holdings, Inc. Registration Statement on Form S-1, as amended File No. 333-283105 Ladies and Gentlemen: Pursuant to Rule 461 promulgated under the Securi |
|
| November 25, 2024 |
As filed with the Securities and Exchange Commission on November 25, 2024 As filed with the Securities and Exchange Commission on November 25, 2024 Registration Statement No. |
|
| November 25, 2024 |
November 25, 2024 Via EDGAR U.S. Securities and Exchange Commission Division of Corporation Finance Office of Life Sciences 100 F Street, N.E. Washington, D.C. 20549 Attn: Ms. Jessica Dickerson / Mr. Joe McCann Re: Bullfrog AI Holdings Inc. Registration Statement on Form S-1 (File No. 333-283105) CIK No. 0001829247 Dear Ms. Dickerson and Mr. McCann: On behalf of Bullfrog AI Holdings Inc. (the “Com |
|
| November 20, 2024 |
November 20, 2024 Vininder Singh Chief Executive Officer BullFrog AI Holdings, Inc. |
|
| November 8, 2024 |
As filed with the Securities and Exchange Commission on November 8, 2024 As filed with the Securities and Exchange Commission on November 8, 2024 Registration Statement No. |
|
| November 8, 2024 |
Exhibit 107 Calculation of Filing Fee Tables Form S-1 (Form Type) BullFrog AI Holdings, Inc. |
|
| November 8, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 001-41600 BULLFROG AI HOLDI |
|
| October 21, 2024 |
Exhibit 4.3 NEITHER THIS SECURITY NOR THE SECURITIES FOR WHICH THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTR |
|
| October 21, 2024 |
Exhibit 10.2 PLACEMENT AGENCY AGREEMENT October 18, 2024 BullFrog AI Holdings, Inc. 325 Ellington Blvd., Unit 317 Gaithersburg, MD 20878 Ladies and Gentlemen: Subject to the terms and conditions herein (this “Agreement”), BullFrog AI Holdings, Inc., a Nevada corporation (the “Company”), hereby agrees to sell up to an aggregate of $3,130,000 of registered and unregistered securities of the Company, |
|
| October 21, 2024 |
Exhibit 99.1 Bullfrog AI Announces Pricing of Registered Direct Offering and Concurrent Private Placement for Aggregate Gross Proceeds of $3.13 Million GAITHERSBURG, Md., Oct. 18, 2024 (GLOBE NEWSWIRE) - BullFrog AI Holdings, Inc. (NASDAQ:BFRG; BFRGW) (“Bullfrog AI” or the “Company”), a technology-enabled drug development company using artificial intelligence (AI) and machine learning to enable th |
|
| October 21, 2024 |
Exhibit 4.1 PRE-FUNDED COMMON STOCK PURCHASE WARRANT BULLFROG AI HOLDINGS, INC. Warrant Shares: Issue Date: October 21, 2024 THIS PRE-FUNDED COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date o |
|
| October 21, 2024 |
Exhibit 99.2 Bullfrog AI Announces Closing of Registered Direct Offering and Concurrent Private Placement for Aggregate Gross Proceeds of $3.13 Million GAITHERSBURG, Md., Oct. 21, 2024 (GLOBE NEWSWIRE) — BullFrog AI Holdings, Inc. (NASDAQ:BFRG; BFRGW) (“Bullfrog AI” or the “Company”), a technology-enabled drug development company using artificial intelligence (AI) and machine learning to enable th |
|
| October 21, 2024 |
Exhibit 4.2 NEITHER THIS SECURITY NOR THE SECURITIES FOR WHICH THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTR |
|
| October 21, 2024 |
Exhibit 10.1 SECURITIES PURCHASE AGREEMENT THIS SECURITIES PURCHASE AGREEMENT (this “Agreement”) is entered into and made effective as of October 18, 2024, by and between BULLFROG AI HOLDINGS, INC., a Nevada corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”). RECITALS |
|
| October 21, 2024 |
Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 18, 2024 BULLFROG AI HOLDINGS, INC. (Exact name of registrant as specified in its charter) Nevada 001-41600 84-4786155 (State or other jurisdiction of incorporation) (Commissi |
|
| October 21, 2024 |
Filed Pursuant to Rule 424(b)(5) Registration No. 333-281341 Prospectus Supplement (to Prospectus dated August 21, 2024) Bullfrog AI Holdings, Inc. 862,602 Shares of Common Stock Pre-Funded Warrants to purchase 702,398 shares of Common Stock (and the shares of Common Stock underlying the Pre-Funded Warrants) Bullfrog AI Holdings, Inc. (the “Company” or “we” or “our” or “us”) is offering (“Offering |
|
| October 15, 2024 |
Exhibit 99.1 BullFrog AI Strengthens Scientific Advisory Board with the Addition of GSK Veteran and Industry Pioneer Dr. John Baldoni GAITHERSBURG, Md. – October 15, 2024 – BullFrog AI, Inc. (NASDAQ: BFRG; BFRGW) (“BullFrog AI” or the “Company”), a technology-enabled drug development company using artificial intelligence (AI) and machine learning to enable the successful development of pharmaceuti |
|
| October 15, 2024 |
Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 15, 2024 BULLFROG AI HOLDINGS, INC. (Exact name of registrant as specified in charter) Nevada 001-41600 84-4786155 (State or other jurisdiction (Commission (IRS Employer of in |
|
| October 9, 2024 |
Exhibit 99.1 BullFrog AI Announces Publication of Data Supporting Potential of Liver Disease Treatment Candidate BF-114 - The study, led by Dr. Lopa Mishra and published in Cell Reports, provides new mechanistic evidence for role of BF-114 target β2-spectrin in obesity, MASLD, MASH, and HCC - The findings suggest that targeting β2-spectrin with BF-114 can prevent the progression of liver diseases |
|
| October 9, 2024 |
Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 9, 2024 BULLFROG AI HOLDINGS, INC. (Exact name of registrant as specified in charter) Nevada 001-41600 84-4786155 (State or other jurisdiction (Commission (IRS Employer of inc |
|
| September 25, 2024 |
Submission of Matters to a Vote of Security Holders UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 20, 2024 BULLFROG AI HOLDINGS, INC. (Exact name of registrant as specified in its charter) Nevada 001-41600 84-4786155 (State or other jurisdiction of incorporation) (Commis |
|
| August 19, 2024 |
BullFrog AI Holdings, Inc. 325 Ellington Blvd., Unit 317 Gaithersburg, MD 20878 (240) 658-6710 BullFrog AI Holdings, Inc. 325 Ellington Blvd., Unit 317 Gaithersburg, MD 20878 (240) 658-6710 August 19, 2024 VIA EDGAR United States Securities and Exchange Commission Division of Corporation Finance 100 F. Street, N.E. Washington, D.C. 20549 Re: BullFrog AI Holdings, Inc. Registration Statement on Form S-3 File No. 333-281341 Ladies and Gentlemen: Pursuant to Rule 461 promulgated under the Secu |
|
| August 15, 2024 |
As filed with the Securities and Exchange Commission on August 15, 2024. As filed with the Securities and Exchange Commission on August 15, 2024. Registration No. 333-281341 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-3 (Amendment No. 1) REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 BULLFROG AI HOLDINGS, INC. (Exact name of registrant as specified in its charter) Nevada 84-4786155 (State or Other Jurisdiction of Incorporatio |
|
| August 13, 2024 |
August 13, 2024 Dane Saglio Chief Financial Officer Bullfrog AI Holdings, Inc. 325 Ellington Blvd., Unit 317 Gaithersburg, MD 20878 Re: Bullfrog AI Holdings, Inc. Registration Statement on Form S-3 Filed August 7, 2024 File No. 333-281341 Dear Dane Saglio: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding re |
|
| August 8, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☒ Definitive |
|
| August 7, 2024 |
Exhibit 107 Calculation of Filing Fee Tables Form S-3 (Form Type) BullFrog AI Holdings, Inc. |
|
| August 7, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 001-41600 BULLFROG AI HOLDINGS, |
|
| August 7, 2024 |
As filed with the Securities and Exchange Commission on August 7, 2024. As filed with the Securities and Exchange Commission on August 7, 2024. Registration No. 333- UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-3 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 BULLFROG AI HOLDINGS, INC. (Exact name of registrant as specified in its charter) Nevada 84-4786155 (State or Other Jurisdiction of Incorporation or Organization) (I.R.S |
|
| July 25, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 25, 2024 BULLFROG AI HOLDINGS, INC. (Exact name of registrant as specified in charter) Nevada 001-41600 84-4786155 (State or other jurisdiction (Commission (IRS Employer of incor |
|
| July 25, 2024 |
Exhibit 99.1 BullFrog AI and Lieber Institute for Brain Development Reveal New Insights into Bipolar Disorder Pathways and Potential Drug Targets Discussions underway for drug target discovery deals with potential pharma partners GAITHERSBURG, Md., July 25, 2024 (GLOBE NEWSWIRE) - BullFrog AI Holdings, Inc. (NASDAQ: BFRG; BFRGW) (“BullFrog AI” or the “Company”), a leader in AI-driven drug discover |
|
| May 16, 2024 |
Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 16, 2024 BULLFROG AI HOLDINGS, INC. (Exact name of registrant as specified in charter) Nevada 001-41600 84-4786155 (State or other jurisdiction (Commission (IRS Employer of incorp |
|
| May 16, 2024 |
Exhibit 99.1 BullFrog AI and Lieber Institute for Brain Development Collaboration Identifies Novel Drug Targets for Neuropsychiatric Disorders Gaithersburg, MD – May 16, 2024 – BullFrog AI Holdings, Inc. (NASDAQ: BFRG; BFRGW) (“BullFrog AI” or the “Company”), a technology-enabled drug discovery company using artificial intelligence (AI) and machine learning to enable the successful discovery and d |
|
| May 10, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 001-41600 BULLFROG AI HOLDINGS, |
|
| April 9, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 9, 2024 BULLFROG AI HOLDINGS, INC. (Exact name of registrant as specified in charter) Nevada 001-41600 84-4786155 (State or other jurisdiction (Commission (IRS Employer of incor |
|
| April 9, 2024 |
Exhibit 99.1 BullFrog AI’s CSO, Tom Chittenden, to Present at the Quantum Computing Symposium at Bio-IT World Conference & Expo Gaithersburg, MD – April 9, 2024 – BullFrog AI Holdings, Inc. (NASDAQ: BFRG; BFRGW) (“BullFrog AI” or the “Company”), a technology-enabled drug development company using artificial intelligence (AI) and machine learning to enable the successful development of pharmaceutic |
|
| March 29, 2024 |
Exhibit 14 Bullfrog AI Holdings, Inc. Code of Business Conduct and Ethics I. Introduction A. Purpose This Code of Business Conduct and Ethics (the “Code”) contains general guidelines for conducting the business of Bullfrog AI Holdings, Inc. (the “Company” or “we”) consistent with the highest standards of business ethics. To the extent this Code requires a higher standard than required by commercia |
|
| March 29, 2024 |
Exhibit 19 Bullfrog AI Holdings, Inc. Insider Trading Compliance Policy This Insider Trading Compliance Policy (this “Policy”) consists of seven sections: ● Section I provides an overview; ● Section II sets forth the policies of the Company prohibiting insider trading; ● Section III explains insider trading; ● Section IV consists of procedures that have been put in place by the Company to prevent |
|
| March 29, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended: December 31, 2023 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from [ ] to [ ] Commission file number 001-41600 BULLFROG |
|
| March 29, 2024 |
Exhibit 97 bullfrog ai holdings, Inc. Compensation Recoupment Policy 1. Restatement. In the event of any required accounting restatement of the financial statements of Bullfrog AI Holdings, Inc. (the “Company”) due to the material noncompliance of the Company with any financial reporting requirement under the applicable U.S. federal securities laws, including any required accounting restatement to |
|
| March 8, 2024 |
Exhibit 99.1 BullFrog AI Announces Availability of Fireside Chat Recording Featuring CEOs of BullFrog AI and the Lieber Institute Gaithersburg, MD – March 7, 2024 – BullFrog AI Holdings, Inc. (NASDAQ: BFRG; BFRGW) (“BullFrog AI” or the “Company”), a technology-enabled drug development company using artificial intelligence (AI) and machine learning to enable the successful development of pharmaceut |
|
| March 8, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 7, 2024 BULLFROG AI HOLDINGS, INC. (Exact name of registrant as specified in charter) Nevada 001-41600 84-4786155 (State or other jurisdiction (Commission (IRS Employer of incor |
|
| February 26, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 26, 2024 BULLFROG AI HOLDINGS, INC. (Exact name of registrant as specified in charter) Nevada 001-41600 84-4786155 (State or other jurisdiction (Commission (IRS Employer of i |
|
| February 26, 2024 |
Exhibit 99.1 BullFrog AI Appoints Globally Renowned Biomedical AI Expert Dr. Thomas W. Chittenden as Chief Scientific Officer Gaithersburg, MD – February 26, 2024 – BullFrog AI Holdings, Inc. (NASDAQ: BFRG; BFRGW) (“BullFrog AI” or the “Company”), a technology-enabled drug development company using artificial intelligence (AI) and machine learning to enable the successful development of pharmaceut |
|
| February 9, 2024 |
Exhibit 99.1 BullFrog AI to Discuss Findings from its Collaboration with Lieber Institute for Brain Development in Fireside Chat Hosted by RedChip Gaithersburg, MD – February 9, 2024 – BullFrog AI Holdings, Inc. (NASDAQ: BFRG; BFRGW) (“BullFrog AI” or the “Company”), a technology-enabled drug development company using artificial intelligence (AI) and machine learning to enable the successful devel |
|
| February 9, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 9, 2024 BULLFROG AI HOLDINGS, INC. (Exact name of registrant as specified in charter) Nevada 001-41600 84-4786155 (State or other jurisdiction (Commission (IRS Employer of in |
|
| February 6, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 31, 2024 BULLFROG AI HOLDINGS, INC. (Exact name of registrant as specified in charter) Nevada 001-41600 84-4786155 (State or other jurisdiction (Commission (IRS Employer of in |
|
| February 6, 2024 |
Form of Common Stock Purchase Warrant (included in Exhibit 4.3) Exhibit 4.3 FORM OF WARRANT AGENT AGREEMENT This Warrant Agent Agreement (this “Warrant Agreement”), dated as of [], 2024 (the “Issuance Date”) is between Bullfrog AI Holdings, Inc., a company incorporated under the laws of the State of Nevada (the “Company”), and VStock Transfer, LLC, a California limited liability company (the “Warrant Agent”). WHEREAS, pursuant to the terms of that certain Unde |
|
| February 6, 2024 |
Form of Pre-Funded Warrant (included in Exhibit 1.1). Exhibit 4.1 BULLFROG AI HOLDINGS, INC. PRE-FUNDED COMMON STOCK PURCHASE WARRANT Warrant Shares: [] Issuance Date: [] THIS PRE-FUNDED COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, [] or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof |
|
| February 6, 2024 |
Bullfrog AI Announces Pricing of $5.7 Million Public Offering Exhibit 99.1 February 1, 2024 Bullfrog AI Announces Pricing of $5.7 Million Public Offering GAITHERSBURG, MD / ACCESSWIRE /February 1, 2024 / BullFrog AI Holdings, Inc. (NASDAQ:BFRG; BFRGW) (“Bullfrog AI” or the “Company”), a technology-enabled drug development company using artificial intelligence (AI) and machine learning to enable the successful development of pharmaceuticals and biologics, ann |
|
| February 6, 2024 |
Exhibit 1.1 BULLFROG AI HOLDINGS, INC. UNDERWRITING AGREEMENT January 31, 2024 WallachBeth Capital LLC Harborside Financial Center Plaza 5 185 Hudson Street, Ste 1410 Jersey City, NJ 07311 As Representative of the Several Underwriters Named on Schedule I hereto Ladies and Gentlemen: BULLFROG AI HOLDINGS, INC., a Delaware corporation (the “Company”), proposes, subject to the terms and conditions st |
|
| February 6, 2024 |
Form of Representative’s Warrant (included in Exhibit 1.1). Exhibit 4.2 THE REGISTERED HOLDER OF THIS COMMON STOCK PURCHASE WARRANT BY ITS ACCEPTANCE HEREOF, AGREES THAT IT WILL NOT SELL, TRANSFER OR ASSIGN THIS COMMON STOCK PURCHASE WARRANT EXCEPT AS HEREIN PROVIDED AND THE REGISTERED HOLDER OF THIS COMMON STOCK PURCHASE WARRANT AGREES THAT IT WILL NOT SELL, TRANSFER, ASSIGN, PLEDGE OR HYPOTHECATE THIS COMMON STOCK PURCHASE WARRANT PURCHASE WARRANT FOR A |
|
| February 6, 2024 |
Bullfrog AI Announces Closing of $5.7 Million Public Offering Exhibit 99.2 February 5, 2024 Bullfrog AI Announces Closing of $5.7 Million Public Offering GAITHERSBURG, MD / ACCESSWIRE /February 5, 2024 / BullFrog AI Holdings, Inc. (NASDAQ:BFRG; BFRGW) (“Bullfrog AI” or the “Company”), a technology-enabled drug development company using artificial intelligence (AI) and machine learning to enable the successful development of pharmaceuticals and biologics, ann |
|
| February 2, 2024 |
File pursuant to Rule 424(b)(3) Registration No. 333-276740 1,028,710 shares of Common Stock And Warrants to Purchase 1,028,710 shares of Common Stock Pre-Funded Warrants to Purchase up 478,429 shares of Common Stock and Warrants to Purchase 478,429 shares of Common Stock Underwriter Warrants to Purchase Up to 90,428 Shares of Common Stock BULLFROG AI HOLDINGS, INC. This is a firm commitment offer |
|
| January 29, 2024 |
[Remainder of Page Intentionally Left Blank] January 29, 2024 VIA EDGAR U.S. Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, DC 20549 Attention: Mr. Daniel Crawford Re: Bullfrog AI Holdings, Inc. Registration Statement on Form S-1 Filed January 29, 2024 File No. 333-276740 Dear Mr. Crawford: Pursuant to Rule 461 under the Securities Act of 1933, as amended (the “Securities Act”), we, as repre |
|
| January 29, 2024 |
Form of Underwriting Agreement Exhibit 1.1 BULLFROG AI HOLDINGS, INC. UNDERWRITING AGREEMENT January , 2024 WallachBeth Capital LLC Harborside Financial Center Plaza 5 185 Hudson Street, Ste 1410 Jersey City, NJ 07311 As Representative of the Several Underwriters Named on Schedule I hereto Ladies and Gentlemen: BULLFROG AI HOLDINGS, INC., a Delaware corporation (the “Company”), proposes, subject to the terms and conditions stat |
|
| January 29, 2024 |
EXHIBIT 107 Calculation of Filing Fee Tables Form S-1 (Form Type) Bullfrog AI Holdings, Inc. |
|
| January 29, 2024 |
As filed with the Securities Exchange Commission on January 29, 2024 As filed with the Securities Exchange Commission on January 29, 2024 Registration No. |
|
| January 29, 2024 |
Exhibit 4.2 THE REGISTERED HOLDER OF THIS COMMON STOCK PURCHASE WARRANT BY ITS ACCEPTANCE HEREOF, AGREES THAT IT WILL NOT SELL, TRANSFER OR ASSIGN THIS COMMON STOCK PURCHASE WARRANT EXCEPT AS HEREIN PROVIDED AND THE REGISTERED HOLDER OF THIS COMMON STOCK PURCHASE WARRANT AGREES THAT IT WILL NOT SELL, TRANSFER, ASSIGN, PLEDGE OR HYPOTHECATE THIS COMMON STOCK PURCHASE WARRANT PURCHASE WARRANT FOR A |
|
| January 29, 2024 |
January 29, 2024 VIA EDGAR Securities and Exchange Commission Division of Corporation Finance 100 F Street N. |
|
| January 29, 2024 |
BULLFROG AI HOLDINGS, INC. 325 Ellington Blvd., Unit 317 Gaithersburg, MD 20878 BULLFROG AI HOLDINGS, INC. 325 Ellington Blvd., Unit 317 Gaithersburg, MD 20878 January 29, 2024 Division of Corporation Finance Office of Life Sciences U.S. Securities and Exchange Commission 100 F Street, NE Washington, D.C. 20549 Attn: Daniel Crawford and Chris Edwards Re: BullFrog AI Holdings, Inc. Draft Registration Statement on Form S-1 Submitted January 19, 2024 CIK No. 0001829247 Dear Mess |
|
| January 29, 2024 |
Form of Company Warrant (included in Exhibit 4.3) Exhibit 4.3 FORM OF WARRANT AGENT AGREEMENT This Warrant Agent Agreement (this “Warrant Agreement”), dated as of [], 2024 (the “Issuance Date”) is between Bullfrog AI Holdings, Inc., a company incorporated under the laws of the State of Nevada (the “Company”), and VStock Transfer, LLC, a California limited liability company (the “Warrant Agent”). WHEREAS, pursuant to the terms of that certain Unde |
|
| January 26, 2024 |
Exhibit 99.1 BullFrog AI Strengthens Scientific Advisory Board with the Addition of Dr. Gwenn Smith and Dr. Jeremiah Wala Gaithersburg, MD – January 26, 2024 – BullFrog AI Holdings, Inc. (NASDAQ: BFRG; BFRGW) (“BullFrog AI” or the “Company”), a technology-enabled drug development company using artificial intelligence (AI) and machine learning to enable the successful development of pharmaceuticals |
|
| January 26, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 26, 2024 BULLFROG AI HOLDINGS, INC. (Exact name of registrant as specified in charter) Nevada 001-41600 84-4786155 (State or other jurisdiction (Commission (IRS Employer of in |
|
| January 24, 2024 |
United States securities and exchange commission logo January 24, 2024 Vininder Singh Chief Executive Officer BullFrog AI Holdings, Inc. |
|
| January 19, 2024 |
As confidentially submitted to the Securities Exchange Commission on January 19, 2024. |
|
| January 17, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 17, 2024 BULLFROG AI HOLDINGS, INC. (Exact name of registrant as specified in charter) Nevada 001-41600 84-4786155 (State or other jurisdiction (Commission (IRS Employer of in |
|
| January 17, 2024 |
Exhibit 99.1 BullFrog AI’s Collaboration with Lieber Institute for Brain Development Yields Potentially Groundbreaking Biological Stratification of Brain Expression Data Gaithersburg, MD – January 17, 2024 – BullFrog AI Holdings, Inc. (NASDAQ: BFRG; BFRGW) (“BullFrog AI” or the “Company”), a technology-enabled drug development company using artificial intelligence (AI) and machine learning to enab |
|
| January 16, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 16, 2024 BULLFROG AI HOLDINGS, INC. (Exact name of registrant as specified in charter) Nevada 001-41600 84-4786155 (State or other jurisdiction (Commission (IRS Employer of in |
|
| January 16, 2024 |
Exhibit 99.1 BullFrog AI Announces Issuance of Australian Patent Protecting Novel Prodrugs of Mebendazole and Their Use in Treating Cancer Issued patent provides protection for BF-223 and related compounds Gaithersburg, MD – Date – BullFrog AI Holdings, Inc. (NASDAQ: BFRG; BFRGW) (“BullFrog AI” or the “Company”), a technology-enabled drug development company using artificial intelligence (AI) and |
|
| December 29, 2023 |
BullFrog AI Issues Letter to Shareholders Exhibit 99.1 BullFrog AI Issues Letter to Shareholders GAITHERSBURG, Md., Dec. 29, 2023 (GLOBE NEWSWIRE) — BullFrog AI Holdings, Inc. (NASDAQ: BFRG; BFRGW) (“BullFrog AI” or the “Company”), a technology-enabled drug development company using artificial intelligence (AI) and machine learning to enable the successful development of pharmaceuticals and biologics, issued a letter to shareholders from |
|
| December 29, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 29, 2023 BULLFROG AI HOLDINGS, INC. (Exact name of registrant as specified in charter) Nevada 001-41600 84-4786155 (State or other jurisdiction (Commission (IRS Employer of i |
|
| November 14, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 001-41600 BULLFROG AI HOLDI |
|
| October 20, 2023 |
Exhibit 10.1 Execution Version COMMERCIAL AGREEMENT This COMMERCIAL AGREEMENT (this “Agreement”) is entered into as of October 16, 2023 (the “Effective Date”), by and between Lieber Institute, Inc. (d/b/a: Lieber Institute for Brain Development) (“LIBD”) and BullFrog AI Management, LLC (“BFAI” or “BullFrogAI”). Each of BFAI and LIBD is sometimes referred to individually herein as a “Party” and col |
|
| October 20, 2023 |
Entry into a Material Definitive Agreement, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 16, 2023 BULLFROG AI HOLDINGS, INC. (Exact name of registrant as specified in charter) Nevada 001-41600 84-4786155 (State or other jurisdiction (Commission (IRS Employer of in |
|
| October 5, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 5, 2023 BULLFROG AI HOLDINGS, INC. (Exact name of registrant as specified in charter) Nevada 001-41600 84-4786155 (State or other jurisdiction (Commission (IRS Employer of inc |
|
| October 5, 2023 |
Exhibit 99.1 BullFrog AI Announces Identification of Novel Potential Drug Targets for Colorectal Cancer Using Its AI-Driven bfLEAP™ Platform Discoveries generated by analyzing The Cancer Genome Atlas using proprietary bfLEAP™ platform Target validation will be conducted through partnership with J. Craig Venter Institute (JCVI), a world-leading institution in genomics research and innovation Gaithe |
|
| September 26, 2023 |
Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 26, 2023 BULLFROG AI HOLDINGS, INC. (Exact name of registrant as specified in charter) Nevada 001-41600 84-4786155 (State or other jurisdiction (Commission (IRS Employer of |
|
| September 26, 2023 |
Investor Presentation Materials Exhibit 99.2 |
|
| September 26, 2023 |
Exhibit 99.1 Healthcare Investor Relations | Corporate Communications | Clinical Trial Patient Recruitment BullFrog AI Announces Positive Data from Preclinical Study Evaluating Novel Prodrug of Mebendazole for Treatment of Glioblastoma BullFrog AI’s patented drug BF-223 Demonstrates Anti-Cancer Activity Against Glioblastoma in Established Animal Model Gaithersburg, MD – September 26, 2023 – BullFr |
|
| September 20, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 20, 2023 BULLFROG AI HOLDINGS, INC. (Exact name of registrant as specified in charter) Nevada 001-41600 84-4786155 (State or other jurisdiction (Commission (IRS Employer of |
|
| September 20, 2023 |
Exhibit 99.1 Healthcare Investor Relations | Corporate Communications | Clinical Trial Patient Recruitment BullFrog AI Announces Launch of BullFrog Data Networks™, a Data Insights Tool Powered by the bfLEAP™ Platform Purpose-built Data Product Offers Customized Visualization of Relationships and Pathways for Specific Disease Indications Built from High-dimension, Multi-modal Data Sets Gaithersburg |
|
| September 14, 2023 |
Exhibit 99.1 Healthcare Investor Relations | Corporate Communications | Clinical Trial Patient Recruitment BullFrog AI Announces Three - Year Global Strategic Partnership with the Lieber Institute for Brain Development The Strategic Collaboration will Leverage Bullfrog AI’s bfLEAP™ AI Platform to Accelerate R&D Initiatives, Including New Drug Target And Disease Biomarker Identification Gaithersbur |
|
| September 14, 2023 |
Exhibit 10.1 Execution Version DATA USE AND TECHNOLOGY PARTNERSHIP AGREEMENT This Data Use and Technology Partnership Agreement (the “Agreement”) is made effective as of September 7, 2023 (“Effective Date”), by and between the Lieber Institute, Inc. (d/b/a: Lieber Institute for Brain Development) (“LIBD”) and BullFrog AI Management, LLC (“BullFrogAI”). LIBD and BullFrogAI are hereinafter individua |
|
| September 14, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 13, 2023 BULLFROG AI HOLDINGS, INC. (Exact name of registrant as specified in charter) Nevada 001-41600 84-4786155 (State or other jurisdiction (Commission (IRS Employer of |
|
| August 14, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 001-41600 BULLFROG AI HOLDINGS, |
|
| July 25, 2023 |
Exhibit 99.1 BullFrog AI Announces Issuance of U.S. Patent Protecting Novel Prodrugs of Mebendazole and Their Use in Treating Cancer Novel compounds show improved bioavailability relative to mebendazole Gaithersburg, MD – July 25, 2023 – BullFrog AI Holdings, Inc. (NASDAQ: BFRG; BFRGW) (“BullFrog AI” or the “Company”), a precision medicine company using artificial intelligence (AI) and machine lea |
|
| July 25, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 25, 2023 BULLFROG AI HOLDINGS, INC. (Exact name of registrant as specified in charter) Nevada 001-41600 84-4786155 (State or other jurisdiction (Commission (IRS Employer of incor |
|
| July 11, 2023 |
Exhibit 99.1 BullFrog AI Announces Appointment of Enrique García-Rivera as Vice President of Artificial Intelligence New VP will enhance development of industry-leading bfLEAP™ AI platform to accelerate and optimize drug discovery process Gaithersburg, MD – July 11, 2023 – BullFrog AI Holdings, Inc. (NASDAQ: BFRG; BFRGW) (“BullFrog AI” or the “Company”), a precision medicine company using artifici |
|
| July 11, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 11, 2023 BULLFROG AI HOLDINGS, INC. (Exact name of registrant as specified in charter) Nevada 001-41600 84-4786155 (State or other jurisdiction (Commission (IRS Employer of incor |
|
| July 3, 2023 |
Exhibit 107 Calculation of Filing Fee Tables Form S-8 (Form Type) Bullfrog AI Holdings, Inc. |
|
| July 3, 2023 |
As filed with the Securities and Exchange Commission on July 03, 2023 As filed with the Securities and Exchange Commission on July 03, 2023 Registration No. |
|
| June 9, 2023 |
Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 9, 2023 BULLFROG AI HOLDINGS, INC. (Exact name of registrant as specified in charter) Nevada 001-41600 84-4786155 (State or other jurisdiction (Commission (IRS Employer of incorp |
|
| June 9, 2023 |
Exhibit 99.1 BullFrog AI CEO Vin Singh to Present at the Gujarati Physicians Convention 2023 More than 1,000 physicians expected to attend the Continuing Medical Education program, where this year’s scientific program theme is “Futuristic Medicine” Gaithersburg, MD – June 9, 2023 – BullFrog AI Holdings, Inc. (NASDAQ:BFRG; BFRGW) (“BullFrog AI” or the “Company”), a precision medicine company using |
|
| June 5, 2023 |
Exhibit 10.1 Amendment No. 1 to License Agreement with BullfrogAI, Inc. The License Agreement, effective July 8, 2021, (“Agreement”) between The Johns Hopkins University Applied Physics Laboratory LLC (“APL”) and BullfrogAI, Inc., a Delaware corporation (“Licensee”) having business offices at 325 Ellington Blvd. #317 Gaithersburg, MD 20878, is, as of June 1, 2023, amended in accordance with Sectio |
|
| June 5, 2023 |
Exhibit 99.1 BullFrog AI Strengthens Capabilities of its AI Platform through Expansion of Licensing Agreement with Johns Hopkins Applied Physics Laboratory Gaithersburg, MD – June 5, 2023 – BullFrog AI Holdings, Inc. (NASDAQ:BFRG; BFRGW) (“BullFrog AI” or the “Company”), a digital technology company using machine learning to usher in a new era of precision medicine, today announced the expansion o |
|
| June 5, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 1, 2023 BULLFROG AI HOLDINGS, INC. (Exact name of registrant as specified in charter) Nevada 001-41600 84-4786155 (State or other jurisdiction (Commission (IRS Employer of incorp |
|
| May 26, 2023 |
BullFrog AI Files Quarterly Report on Form 10-Q Exhibit 99.1 BullFrog AI Files Quarterly Report on Form 10-Q Gaithersburg, MD – May 26, 2023 – BullFrog AI Holdings, Inc. (NASDAQ:BFRG; BFRGW) (“BullFrog AI” or the “Company”), a digital technology company using machine learning to usher in a new era of precision medicine, today announced it filed its Form 10-Q with the Securities and Exchange Commission (“SEC”) for the quarter ended March 31, 202 |
|
| May 26, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 23, 2023 BULLFROG AI HOLDINGS, INC. (Exact name of registrant as specified in charter) Nevada 001-41600 84-4786155 (State or other jurisdiction (Commission (IRS Employer of incorp |
|
| May 24, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 0-19437 BULLFROG AI HOLDINGS, I |
|
| May 16, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 12b-25 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 12b-25 SEC FILE NUMBER 001-41600 CUSIP NUMBER 12021E NOTIFICATION OF LATE FILING (Check One) ☐ Form 10-K ☐ Form 20-F ☐ Form 11-K ☒ Form 10-Q ☐ Form 10-D ☐ Form N-CEN ☐ Form N-CSR For Period Ended: March 31, 2023 ☐ Transition Report on Form 10-K ☐ Transition Report on Form 20-F ☐ Transition Report on Form 11-K ☐ Transition |
|
| April 25, 2023 |
Exhibit 10.10 BULLFROG AI HOLDINGS, INC. 2022 EQUITY INCENTIVE PLAN As adopted by the Board of Directors of Bullfrog AI Holdings, Inc. on November 30, 2022. As approved by the shareholders of Bullfrog AI Holdings, Inc. on November 30, 2022. 1. Purpose; Eligibility. 1.1 General Purpose. The name of this plan is the Bullfrog AI Holdings, Inc., 2022 Equity Incentive Plan (the “Plan”). The purposes of |
|
| April 25, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended: December 31, 2022 ☐ TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from [ ] to [ ] Commission file number 001-41600 BULLFROG AI HOLDINGS, |
|
| April 25, 2023 |
BullFrog AI Files 2022 Annual Report on Form 10-K Exhibit 99.1 BullFrog AI Files 2022 Annual Report on Form 10-K Gaithersburg, MD – April 25, 2023 – BullFrog AI Holdings, Inc. (NASDAQ:BFRG; BFRGW) (“BullFrog AI” or the “Company”), a digital technology company using machine learning to usher in a new era of precision medicine, today announced it filed its Form 10-K with the Securities and Exchange Commission (“SEC”) for its year ended December 31, |
|
| April 25, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 19, 2023 BULLFROG AI HOLDINGS, INC. (Exact name of registrant as specified in charter) Nevada 001-41600 84-4786155 (State or other jurisdiction (Commission (IRS Employer of inco |
|
| April 3, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING SEC FILE NUMBER 001-41600 CUSIP NUMBER 12021E (Check One): ☒ Form 10-K ☐ Form 20-F ☐ Form 11-K ☐ Form 10-Q ☐ Form N-SAR ☐ Form N-CSR For Period Ended: December 31, 2022 ☐ Transition Report on Form 10-K ☐ Transition Report on Form 20-F ☐ Transition Report on Form 11-K ☐ Transition Report |
|
| February 21, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 14, 2023 BULLFROG AI HOLDINGS, INC. (Exact name of registrant as specified in charter) Nevada 001-41600 84-4786155 (State or other jurisdiction (Commission (IRS Employer of i |
|
| February 21, 2023 |
Exhibit 1.2 WARRANT AGENT AGREEMENT This Warrant Agent Agreement (this “Warrant Agreement”), dated as of February 16, 2023 (the “Issuance Date”) is between Bullfrog AI Holdings, Inc., a company incorporated under the laws of the State of Nevada (the “Company”), and VStock Transfer, LLC, a California limited liability company (the “Warrant Agent”). WHEREAS, pursuant to the terms of that certain Und |
|
| February 21, 2023 |
EX-1.1 2 ex1-1.htm Exhibit 1.1 BULLFROG AI HOLDINGS, INC. UNDERWRITING AGREEMENT 1,297,318 Units, Each Consisting of One Share of Common Stock, One Warrant to Purchase One Share of Common Stock, and One Non-tradeable Warrant to Purchase One Share of Common Stock February 14, 2023 WallachBeth Capital LLC Harborside Financial Center Plaza 5 185 Hudson Street, Ste 1410 Jersey City, NJ 07311 As Repres |
|
| February 21, 2023 |
Press Release dated February 16, 2023 Exhibit 99.2 |
|
| February 21, 2023 |
Press Release dated February 14, 2023 Exhibit 99.1 |
|
| February 16, 2023 |
PROSPECTUS Filed Pursuant to Rule 424(b)(4) Registration No. 333-267951 1,297,318 Units Each Unit Consisting of One Share of Common Stock, One Warrant to Purchase One share of Common Stock, and One Non-tradeable Warrant to Purchase One Share of Common Stock and the 2,594,636 Shares of Common Stock underlying such Warrants BULLFROG AI HOLDINGS, INC. This is a firm commitment initial public offering |
|
| February 14, 2023 |
Eun Ah Choi Senior Vice President U.S. Listing Qualifications & Market Surveillance February 14, 2022 Division of Corporation Finance U.S. Securities and Exchange Commission 100 F Street, N.E. Washington, D.C. 20549 Division of Corporation Finance: This is to certify that on January 23, 2023 The Nasdaq Stock Market (the "Exchange") received from Bullfrog AI Holdings, Inc. (the "Registrant") a copy |
|
| February 13, 2023 |
CORRESP 1 filename1.htm WallachBeth Capital, LLC Harborside Financial Plaza 5 185 Hudson St., Suite 1410 Jersey City, NJ 07311 February 10, 2023 VIA EDGAR CORRESPONDENCE U.S. Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549 Re: Bullfrog AI Holdings, Inc. Registration Statement on Form S-1 (Registration No. 333-267951) Concurrence in Accel |
|
| February 13, 2023 |
As filed with the Securities Exchange Commission on February 13, 2023 As filed with the Securities Exchange Commission on February 13, 2023 Registration No. |
|
| February 10, 2023 |
CORRESP 1 filename1.htm February 10, 2023 VIA EDGAR Securities and Exchange Commission Division of Corporation Finance 100 F Street N.E. Washington, D.C. 20549 Re: Bullfrog AI Holdings, Inc Registration Statement on Form S-1 (the “Registration Statement”) File No. 333-267951 Ladies and Gentlemen: Pursuant to Rule 461 promulgated under the Securities Act of 1933, as amended, Bullfrog AI Holdings, I |
|
| February 10, 2023 |
February 10, 2023 VIA EDGAR Securities and Exchange Commission Division of Corporation Finance 100 F Street N. |
|
| February 8, 2023 |
CORRESP 1 filename1.htm February 8, 2023 VIA EDGAR Securities and Exchange Commission Division of Corporation Finance 100 F Street N.E. Washington, D.C. 20549 Re: Bullfrog AI Holdings, Inc Withdrawal of Acceleration Request - Registration Statement on Form S-1 File No. 333-267951 Ladies and Gentlemen: Reference is made to our letter, filed as correspondence via EDGAR on February 1, 2023 , in which |
|
| February 7, 2023 |
February 7, 2023 VIA EDGAR Securities and Exchange Commission Division of Corporation Finance 100 F Street N. |
|
| February 7, 2023 |
CORRESP 1 filename1.htm WallachBeth Capital, LLC Harborside Financial Plaza 5 185 Hudson St., Suite 1410 Jersey City, NJ 07311 February 7, 2023 VIA EDGAR CORRESPONDENCE U.S. Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549 Re: Bullfrog AI Holdings, Inc. Registration Statement on Form S-1 (Registration No. 333-267951) Concurrence in Accele |
|
| February 1, 2023 |
WallachBeth Capital, LLC Harborside Financial Plaza 5 185 Hudson St., Suite 1410 Jersey City, NJ 07311 February 1, 2023 VIA EDGAR CORRESPONDENCE U.S. Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549 Re: Bullfrog AI Holdings, Inc. Registration Statement on Form S-1 (Registration No. 333-267951) Concurrence in Acceleration Request Ladies an |
|
| February 1, 2023 |
February 1, 2023 VIA EDGAR Securities and Exchange Commission Division of Corporation Finance 100 F Street N. |
|
| January 31, 2023 |
January 31, 2023 VIA EDGAR Securities and Exchange Commission Division of Corporation Finance 100 F Street N. |
|
| January 23, 2023 |
January 23, 2023 VIA EDGAR Securities and Exchange Commission Division of Corporation Finance 100 F Street N. |
|
| January 23, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-A FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934 BULLFROG AI HOLDINGS, INC. (Exact name of registrant as specified in its charter) Nevada 84-4786155 (State or incorporation or organization) (I.R.S. Employer Identification No.) 325 Ellington Blvd. |
|
| January 23, 2023 |
CORRESP 1 filename1.htm WallachBeth Capital, LLC Harborside Financial Plaza 5 185 Hudson St., Suite 1410 Jersey City, NJ 07311 January 23, 2023 VIA EDGAR CORRESPONDENCE U.S. Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549 Re: Bullfrog AI Holdings, Inc. Registration Statement on Form S-1 (Registration No. 333-267951) Concurrence in Accele |
|
| January 17, 2023 |
United States securities and exchange commission logo January 17, 2023 Vininder Singh Chief Executive Officer BullFrog AI Holdings, Inc. |
|
| January 17, 2023 |
BullFrog AI Holdings, Inc. 325 Ellington Blvd., Unit 317 Gaithersburg, MD 20878 CORRESP 1 filename1.htm BullFrog AI Holdings, Inc. 325 Ellington Blvd., Unit 317 Gaithersburg, MD 20878 January 17, 2023 Tyler Howes Division of Corporation Finance Office of Life Sciences Securities and Exchange Commission 100 F Street, NE Washington, D.C. 20549 Re: BullFrog AI Holdings, Inc. Amendment No. 4 to Registration Statement on Form S-1 Filed January 10, 2023 File No. 333-267951 Dear Mr. |
|
| January 10, 2023 |
Exhibit 4.8 [FORM OF NON-TRADEABLE WARRANT] THE NUMBER OF SHARES OF COMMON STOCK ISSUABLE UPON EXERCISE OF THIS WARRANT MAY BE LESS THAN THE AMOUNTS SET FORTH ON THE FACE HEREOF PURSUANT TO SECTION 1(d) OF THIS WARRANT. BULLFROG AI HOLDINGS, INC. Non-tradeable Warrant To Purchase Common Stock Warrant No.: Date of Issuance: [*], 2023 (“Issuance Date”) Bullfrog AI Holdings, Inc., a Nevada corporatio |
|
| January 10, 2023 |
EX-FILING FEES 8 ex107.htm CALCULATION OF FILING FEE TABLES EXHIBIT 107 Calculation of Filing Fee Tables Form S-1 (Form Type) Bullfrog AI Holdings, Inc. (Exact Name of Registrant as Specified in its Charter) Table 1: Newly Registered Securities Security Type Security Class Title Fee Calculation or Carry Forward Rule Amount Registered Proposed Maximum Offering Price Per Unit Maximum Aggregate Offer |
|
| January 10, 2023 |
Exhibit 4.4 FORM OF WARRANT AGENT AGREEMENT This Warrant Agent Agreement (this “Warrant Agreement”), dated as of [], 2023 (the “Issuance Date”) is between Bullfrog AI Holdings, Inc., a company incorporated under the laws of the State of Nevada (the “Company”), and VStock Transfer, LLC, a California limited liability company (the “Warrant Agent”). WHEREAS, pursuant to the terms of that certain Unde |
|
| January 10, 2023 |
As filed with the Securities Exchange Commission on January 10, 2023 As filed with the Securities Exchange Commission on January 10, 2023 Registration No. |
|
| January 10, 2023 |
Form of Convertible Promissory Note Exhibit 4.7 [FORM OF NON-TRADEABLE WARRANT] THE NUMBER OF SHARES OF COMMON STOCK ISSUABLE UPON EXERCISE OF THIS WARRANT MAY BE LESS THAN THE AMOUNTS SET FORTH ON THE FACE HEREOF PURSUANT TO SECTION 1(d) OF THIS WARRANT. BULLFROG AI HOLDINGS, INC. Non-tradeable Warrant To Purchase Common Stock Warrant No.: Date of Issuance: [*], 2023 (“Issuance Date”) Bullfrog AI Holdings, Inc., a Nevada corporatio |
|
| January 10, 2023 |
Form of Underwriting Agreement Exhibit 1.1 BULLFROG AI HOLDINGS, INC. UNDERWRITING AGREEMENT 1,317,647 Units, Each Consisting of One Share of Common Stock, One Warrant to Purchase One Share of Common Stock, and One Non-tradeable Warrant to Purchase One Share of Common Stock January , 2023 WallachBeth Capital LLC Harborside Financial Center Plaza 5 185 Hudson Street, Ste 1410 Jersey City, NJ 07311 As Representative of the Severa |
|
| December 8, 2022 |
Exhibit 10.7 EXCLUSIVE LICENSE AGREEMENT Johns Hopkins University and BullFrog AI Holdings, Inc. JHU Agreement Number A40219 This AGREEMENT is entered into by and between the Johns Hopkins University (?JHU?), a Maryland corporation having an address at 3400 N. Charles Street, Baltimore, Maryland, 21218- 2695, and BullFrog AI Holdings, Inc., (?LICENSEE?), a Nevada corporation having an address at 3 |
|
| December 8, 2022 |
BullFrog AI Holdings, Inc. 325 Ellington Blvd., Unit 317 Gaithersburg, MD 20878 BullFrog AI Holdings, Inc. 325 Ellington Blvd., Unit 317 Gaithersburg, MD 20878 December 8, 2022 Tyler Howes Division of Corporation Finance Office of Life Sciences Securities and Exchange Commission 100 F Street, NE Washington, D.C. 20549 Re: BullFrog AI Holdings, Inc. Amendment No. 2 to Draft Registration Statement on Form S-1 Submitted November 28, 2022 File No. 333-267951 Dear Mr. Howes: On be |
|
| December 8, 2022 |
Exhibit 14.1 BULLFROG AI HOLDINGS, INC. CODE OF BUSINESS CONDUCT AND ETHICS 1. Introduction. The Board of Directors of Bullfrog AI Holdings, Inc. (together with its subsidiaries, the ?Company?) has adopted this Code of Business Conduct and Ethics (the ?Code?) in order to: ? promote honest and ethical conduct, including the ethical handling of actual or apparent conflicts of interest; ? promote ful |
|
| December 8, 2022 |
Exhibit 10.6 CONFIDENTIAL THE GEORGE WASHINGTON UNIVERSITY Patent License Agreement This Patent License Agreement (this ?Agreement?) is between the George Washington University, a congressionally chartered not-for-profit corporation (?University?) located in the District of Columbia, and BullFrog AI Holdings, Inc., a Nevada corporation, having a principal place of business at 325 Ellington Blvd., |
|
| December 8, 2022 |
Exhibit 10.9 |
|
| December 8, 2022 |
Exhibit 10.5 LICENSE AGREEMENT This License Agreement (?Agreement?) is between The Johns Hopkins University Applied Physics Laboratory LLC, a Maryland limited liability company, with its principal office at 11100 Johns Hopkins Road, Laurel, MD 20723-6099 (hereinafter ?JHU/APL?) and Bullfrog Al Inc. (hereinafter ?Company?), having an address at PO Box 336, Boyds, MD 20841. This Agreement consists o |
|
| December 8, 2022 |
As filed with the Securities Exchange Commission on December 8, 2022 As filed with the Securities Exchange Commission on December 8, 2022 Registration No. |
|
| December 8, 2022 |
EX-21.1 8 ex21-1.htm Exhibit 21.1 List of Subsidiaries of Norwegian Cruise Line Holdings Ltd. Name of Subsidiary Jurisdiction of Incorporation or Organization BullFrog AI, Inc Nevada BullFrog Management, LLC Nevada |
|
| December 8, 2022 |
Exhibit 10.8 APL PROPRIETARY/CONFIDENTIAL BullfrogAI Prometheus License, July 2022 LICENSE AGREEMENT This license agreement (the ?Agreement?) is entered into and made effective as of July 8, 2022 (the ?Effective Date?) between The Johns Hopkins University Applied Physics Laboratory LLC, a Maryland limited liability company, having business offices at 11100 Johns Hopkins Road, Laurel, Maryland 2072 |
|
| December 7, 2022 |
United States securities and exchange commission logo December 6, 2022 Vininder Singh Chief Executive Officer BullFrog AI Holdings, Inc. |
|
| November 28, 2022 |
BullFrog AI Holdings, Inc. 325 Ellington Blvd., Unit 317 Gaithersburg, MD 20878 BullFrog AI Holdings, Inc. 325 Ellington Blvd., Unit 317 Gaithersburg, MD 20878 November 28, 2022 Tyler Howes Division of Corporation Finance Office of Life Sciences Securities and Exchange Commission 100 F Street, NE Washington, D.C. 20549 Re: BullFrog AI Holdings, Inc. Amendment No.1 to Draft Registration Statement on Form S-1 Submitted November 7, 2022 File No. 333-267951 Dear Mr. Howes: On beh |
|
| November 28, 2022 |
EX-14.1 5 ex14-1.htm Exhibit 14.1 BULLFROG AI HOLDINGS, INC. CODE OF BUSINESS CONDUCT AND ETHICS 1. Introduction. The Board of Directors of Bullfrog AI Holdings, Inc. (together with its subsidiaries, the “Company”) has adopted this Code of Business Conduct and Ethics (the “Code”) in order to: ● promote honest and ethical conduct, including the ethical handling of actual or apparent conflicts of in |
|
| November 28, 2022 |
EX-FILING FEES 8 ex107.htm EXHIBIT 107 Calculation of Filing Fee Tables Form S-1 (Form Type) Bullfrog AI Holdings, Inc. (Exact Name of Registrant as Specified in its Charter) Table 1: Newly Registered Securities Security Type Security Class Title Fee Calculation or Carry Forward Rule Amount Registered Proposed Maximum Offering Price Per Unit Maximum Aggregate Offering Price Fee Rate Amount of Regi |
|
| November 28, 2022 |
As filed with the Securities Exchange Commission on November 28, 2022 As filed with the Securities Exchange Commission on November 28, 2022 Registration No. |
|
| November 28, 2022 |
Exhibit 10.6 EXCLUSIVE LICENSE AGREEMENT Johns Hopkins University and BullFrog AI Holdings, Inc. JHU Agreement Number A40219 This AGREEMENT is entered into by and between the Johns Hopkins University (?JHU?), a Maryland corporation having an address at 3400 N. Charles Street, Baltimore, Maryland, 21218- 2695, and BullFrog AI Holdings, Inc., (?LICENSEE?), a Nevada corporation having an address at 3 |
|
| November 28, 2022 |
EX-10.5 2 ex10-5.htm Exhibit 10.5 CONFIDENTIAL THE GEORGE WASHINGTON UNIVERSITY Patent License Agreement This Patent License Agreement (this “Agreement”) is between the George Washington University, a congressionally chartered not-for-profit corporation (“University”) located in the District of Columbia, and BullFrog AI Holdings, Inc., a Nevada corporation, having a principal place of business at |
|
| November 28, 2022 |
List of significant subsidiaries of Bullfrog AI Holdings, Inc. Exhibit 21.1 List of Subsidiaries of Norwegian Cruise Line Holdings Ltd. Name of Subsidiary Jurisdiction of Incorporation or Organization BullFrog AI, Inc Nevada BullFrog Management, LLC Nevada |
|
| November 28, 2022 |
Exhibit 10.7 APL PROPRIETARY/CONFIDENTIAL BullfrogAI Prometheus License, July 2022 LICENSE AGREEMENT This license agreement (the ?Agreement?) is entered into and made effective as of July 8, 2022 (the ?Effective Date?) between The Johns Hopkins University Applied Physics Laboratory LLC, a Maryland limited liability company, having business offices at 11100 Johns Hopkins Road, Laurel, Maryland 2072 |
|
| November 15, 2022 |
United States securities and exchange commission logo November 15, 2022 Vininder Singh Chief Executive Officer BullFrog AI Holdings, Inc. |
|
| November 7, 2022 |
Exhibit 14.1 BULLFROG AI HOLDINGS, INC. CODE OF BUSINESS CONDUCT AND ETHICS 1. Introduction. The Board of Directors of Bullfrog AI Holdings, Inc. (together with its subsidiaries, the “Company”) has adopted this Code of Business Conduct and Ethics (the “Code”) in order to: ● promote honest and ethical conduct, including the ethical handling of actual or apparent conflicts of interest; ● promote ful |
|
| November 7, 2022 |
Exhibit 99.4 Consent to be Named as a Director Nominee In connection with the filing by BullFrog AI Holdings, Inc. of the Registration Statement on Form S-1 with the Securities and Exchange Commission under the Securities Act of 1933, as amended (the ?Securities Act?), I hereby consent, pursuant to Rule 438 of the Securities Act, to being named as a nominee to the board of directors of BullFrog AI |
|
| November 7, 2022 |
As filed with the Securities Exchange Commission on November 7, 2022 As filed with the Securities Exchange Commission on November 7, 2022 Registration No. |
|
| November 7, 2022 |
Exhibit 99.5 Consent to be Named as a Director Nominee In connection with the filing by BullFrog AI Holdings, Inc. of the Registration Statement on Form S-1 with the Securities and Exchange Commission under the Securities Act of 1933, as amended (the ?Securities Act?), I hereby consent, pursuant to Rule 438 of the Securities Act, to being named as a nominee to the board of directors of BullFrog AI |
|
| November 7, 2022 |
BullFrog AI Holdings, Inc. 325 Ellington Blvd., Unit 317 Gaithersburg, MD 20878 BullFrog AI Holdings, Inc. 325 Ellington Blvd., Unit 317 Gaithersburg, MD 20878 November 7, 2022 Tyler Howes Division of Corporation Finance Office of Life Sciences Securities and Exchange Commission 100 F Street, NE Washington, D.C. 20549 Re: BullFrog AI Holdings, Inc. Registration Statement on Form S-1 Filed October 19, 2022 CIK No. 0001829247 Dear Mr. Howes: On behalf of BullFrog AI Holdings, I |
|
| November 7, 2022 |
EX-99.3 5 ex99-3.htm Exhibit 99.3 Consent to be Named as a Director Nominee In connection with the filing by BullFrog AI Holdings, Inc. of the Registration Statement on Form S-1 with the Securities and Exchange Commission under the Securities Act of 1933, as amended (the “Securities Act”), I hereby consent, pursuant to Rule 438 of the Securities Act, to being named as a nominee to the board of dir |
|
| November 7, 2022 |
List of significant subsidiaries of Bullfrog AI Holdings, Inc. Exhibit 21.1 List of Subsidiaries of Norwegian Cruise Line Holdings Ltd. Name of Subsidiary Jurisdiction of Incorporation or Organization BullFrog AI, Inc Nevada BullFrog Management, LLC Nevada |
|
| November 7, 2022 |
EX-FILING FEES 8 ex107.htm EXHIBIT 107 Calculation of Filing Fee Tables Form S-1 (Form Type) Bullfrog AI Holdings, Inc. (Exact Name of Registrant as Specified in its Charter) Table 1: Newly Registered Securities Security Type Security Class Title Fee Calculation or Carry Forward Rule Amount Registered Proposed Maximum Offering Price Per Unit Maximum Aggregate Offering Price Fee Rate Amount of Regi |
|
| November 3, 2022 |
United States securities and exchange commission logo November 3, 2022 Vininder Singh Chief Executive Officer BullFrog AI Holdings, Inc. |
|
| October 19, 2022 |
EX-FILING FEES 22 ex107.htm CALCULATION OF FILING FEE TABLES EXHIBIT 107 Calculation of Filing Fee Tables Form S-1 (Form Type) Bullfrog AI Holdings, Inc. (Exact Name of Registrant as Specified in its Charter) Table 1: Newly Registered Securities Security Type Security Class Title Fee Calculation or Carry Forward Rule Amount Registered Proposed Maximum Offering Price Per Unit Maximum Aggregate Offe |
|
| October 19, 2022 |
Consulting Agreement between the Company and Garrett Newman Exhibit 10.4 Gerald R. Newman & Associates 162 N. Hamel Drive Suite 101 Beverly Hills, California 90211 Tel. (310) 871-3996 Fax (310) 289-1015 Email [email protected] June 23, 2021 PERSONAL AND CONFIDENTIAL BullFrog AI Holdings, Inc. 325 Ellington Blvd., #317 Gaithersburg, MD 20878 Attn: Vin Singh ? Chief Executive Officer Dear Mr. Singh, This Business Services Development Agreement (the ?Agreem |
|
| October 19, 2022 |
EX-10.1 11 ex10-1.htm Exhibit 10.1 EXCHANGE AGREEMENT This Exchange Agreement is made this 2nd day of June, 2020 by and between Bullfrog AI Holdings, Inc. a Nevada corporation (“Holdings”), and Vininder (Vin) Singh. W I T N E S S E T H WHEREAS, Vininder Singh (“Shareholder”) desires to exchange his shares in Bullfrog AI, Inc., a Delaware corporation, Bullfrog Delaware for shares in Holdings; WHERE |
|
| October 19, 2022 |
Exhibit 10.5 |
|
| October 19, 2022 |
EX-99.5 21 ex99-5.htm Exhibit 99.5 Consent to be Named as a Director Nominee In connection with the filing by BullFrog AI Holdings, Inc. of the Registration Statement on Form S-1 with the Securities and Exchange Commission under the Securities Act of 1933, as amended (the “Securities Act”), I hereby consent, pursuant to Rule 438 of the Securities Act, to being named as a nominee to the board of di |
|
| October 19, 2022 |
EX-4.3 6 ex4-3.htm Exhibit 4.3 NEITHER THIS SECURITY NOR THE SECURITIES FOR WHICH THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933 (THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE |
|
| October 19, 2022 |
Exhibit 3.1 |
|
| October 19, 2022 |
Exhibit 3.2 |
|
| October 19, 2022 |
Exhibit 99.4 Consent to be Named as a Director Nominee In connection with the filing by BullFrog AI Holdings, Inc. of the Registration Statement on Form S-1 with the Securities and Exchange Commission under the Securities Act of 1933, as amended (the ?Securities Act?), I hereby consent, pursuant to Rule 438 of the Securities Act, to being named as a nominee to the board of directors of BullFrog AI |
|
| October 19, 2022 |
Exhibit 10.2 APL proprietary/confidential BullfrogAI Prometheus License, July 2022 LICENSE AGREEMENT This license agreement (the ?Agreement?) is entered into and made effective as of July 8, 2022 (the ?Effective Date?) between The Johns Hopkins University Applied Physics Laboratory LLC, a Maryland limited liability company, having business offices at 11100 Johns Hopkins Road, Laurel, Maryland 2072 |
|
| October 19, 2022 |
Form of Securities Purchase Agreement Exhibit 4.6 SECURITIES PURCHASE AGREEMENT This Securities Purchase Agreement (this ?Agreement?) is dated as of April [*], 2022, by and between BullFrog AI Holdings, Inc., a Nevada corporation (the ?Company?), and each lender party that executes the signature page hereto as a purchaser (each, a ?Purchaser? and collectively, the ?Purchasers?). WHEREAS, subject to the terms and conditions set forth i |
|
| October 19, 2022 |
Charter of Compensation Committee EX-99.2 18 ex99-2.htm Exhibit 99.2 CHARTER OF THE COMPENSATION COMMITTEE OF BULLFROG AI HOLDINGS, INC. Membership The Compensation Committee (the “Committee”) of the board of directors (the “Board”) of Bullfrog AI Holdings, Inc. (the “Company”) shall consist of two or more directors. Each member of the Committee shall be independent in accordance with the rules of the NASDAQ Stock Market LLC (“NAS |
|
| October 19, 2022 |
Form of Convertible Promissory Note Exhibit 4.7 NEITHER THIS SECURITY NOR THE SECURITIES INTO WHICH THIS SECURITY IS CONVERTIBLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE ?SECURITIES ACT?), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGIST |
|
| October 19, 2022 |
Form of Underwriting Agreement EX-1.1 2 ex1-1.htm Exhibit 1.1 BULLFROG AI HOLDINGS, INC. UNDERWRITING AGREEMENT [*] Units Consisting of [*] Shares of Common Stock, And Warrants to Purchase [*] Shares of Common Stock \ October , 2022 WallachBeth Capital LLC Harborside Financial Center Plaza 5 185 Hudson Street, Ste 1410 Jersey City, NJ 07311 As Representative of the Several Underwriters Named on Schedule I hereto Ladies and Gent |
|
| October 19, 2022 |
As filed with the Securities Exchange Commission on October 19, 2022 As filed with the Securities Exchange Commission on October 19, 2022 Registration No. |
|
| October 19, 2022 |
Exhibit 99.3 Consent to be Named as a Director Nominee In connection with the filing by BullFrog AI Holdings, Inc. of the Registration Statement on Form S-1 with the Securities and Exchange Commission under the Securities Act of 1933, as amended (the ?Securities Act?), I hereby consent, pursuant to Rule 438 of the Securities Act, to being named as a nominee to the board of directors of BullFrog AI |
|
| October 19, 2022 |
Exhibit 99.1 CHARTER OF THE AUDIT COMMITTEE OF BULLFROG AI HOLDINGS, INC. Membership The Audit Committee (the ?Committee?) of the board of directors (the ?Board?) of Bullfrog AI Holdings, Inc. (the ?Company?) shall consist of three or more directors. Each member of the Committee shall be independent in accordance with the requirements of Rule 10A-3 of the Securities Exchange Act of 1934 and the ru |
|
| October 19, 2022 |
Exhibit 4.4 WARRANT AGENT AGREEMENT This Warrant Agent Agreement (this ?Warrant Agreement?), dated as of October [], 2022 (the ?Issuance Date?) between Bullfrog AI Holdings, Inc., a company incorporated under the laws of the State of Nevada (the ?Company?), and VStock Transfer, LLC, a California limited liability company (the ?Warrant Agent?). WHEREAS, pursuant to the terms of that certain Underwr |
|
| October 19, 2022 |
Form of Registrant’s Common Stock certificate Exhibit 4.1 |
|
| October 19, 2022 |
Advisor Agreement between the Company and Greentree Financial Group, Inc. EX-10.3 13 ex10-3.htm Exhibit 10.3 Greentree Financial Group, Inc. FL Office 7951 SW 6th St., Ste. 216 Plantation, Florida 33324 Tel: 954-424-2345 Fax:954-424-2230 NC Office 19720 Jetton Road, 3rd Floor Cornelius, NC 28301 Tel: 704-892-8733 Fax:704-892-6487 June 23, 2021 PERSONAL AND CONFIDENTIAL BullFrog AI Holdings, Inc. 325 Ellington Blvd., #317 Gaithersburg, MD 20878 Attn: Vin Singh – Chief Ex |
|
| October 19, 2022 |
BullFrog AI Holdings, Inc. 325 Ellington Blvd., Unit 317 Gaithersburg, MD 20878 BullFrog AI Holdings, Inc. 325 Ellington Blvd., Unit 317 Gaithersburg, MD 20878 October 19, 2022 Tyler Howes Division of Corporation Finance Office of Life Sciences Securities and Exchange Commission 100 F Street, NE Washington, D.C. 20549 Re: BullFrog AI Holdings, Inc. Amendment No.1 to Draft Registration Statement on Form S-1 Submitted August 15, 2022 CIK No. 0001829247 Dear Mr. Howes: On behalf |
